Citalopram and Escitalopram – Risk of QT interval prolongation - Irish Medical Times
Citalopram and Escitalopram – Risk of QT interval prolongationIrish Medical TimesCitalopram and escitalopram are selective serotonin reuptake inhibitors (SSRIs) indicated in the treatment of depressive illness (see the Summaries of Product Characteristics (SPCs) for full details of licensed indications).
Clinical and Research News - Psychiatric News
Clinical and Research NewsPsychiatric NewsAdditionally, the review of some mixed-treatment comparisons showed that patients had a greater response to escitalopram when compared with both duloxetine and fluoxetine.
SSRIs During Pregnancy May Up Risk of Rare Disorder - PsychCentral.com
PsychCentral.
Less is More When Treating Depression - dailyRx
Less is More When Treating DepressiondailyRxResearchers find the use of escitalopram, bupropion-SR, venlafaxine, and mirtazapine to be as safe and effective for patients with multiple (co-morbid) health issues.
LawyersandSettlements.com Recognizes American Heart Month With Its Top 10 ... - MarketWatch (press release)